Hospital-Acquired Infections (HAI) and Medical Negligence in New York

What Are Hospital-Acquired Infections (HAIs)?

A hospital-acquired infection is defined as an infection that develops 48 hours or more after hospital admission, or within 30 days after discharge (or 90 days for surgical site infections). The 48-hour rule distinguishes community-acquired infections (present on admission) from nosocomial infections (acquired in the hospital).

HAIs occur because hospitals are environments where sick patients, invasive procedures, and antibiotic-resistant bacteria converge. Patients in hospitals are often immunocompromised, have open wounds or surgical incisions, and are connected to invasive devices (catheters, central lines, ventilators) that bypass the body's natural defenses. When infection prevention protocols are not followed, bacteria can enter the body and cause serious — sometimes fatal — infections.

The CDC estimates that approximately 1.7 million HAIs occur each year in U.S. hospitals, contributing to nearly 100,000 deaths. Many of these are preventable through adherence to evidence-based infection prevention practices.

The Most Common Hospital-Acquired Infections

The most common hospital-acquired infections include:

• MRSA (Methicillin-Resistant Staphylococcus Aureus): A antibiotic-resistant staph infection that can cause bloodstream infections, surgical site infections, and pneumonia.
• Clostridioides difficile (C. diff): A bacterial infection of the colon causing severe, sometimes fatal, diarrhea, often triggered by antibiotic use that disrupts normal gut flora.
• Surgical Site Infections (SSIs): Infections at the site of a surgical incision, ranging from superficial skin infections to deep organ/space infections.
• Central Line-Associated Bloodstream Infections (CLABSIs): Infections that enter the bloodstream through central venous catheters, causing sepsis.
• Catheter-Associated Urinary Tract Infections (CAUTIs): Urinary tract infections caused by urinary catheters.
• Ventilator-Associated Pneumonia (VAP): Pneumonia that develops in patients on mechanical ventilation.
• Vancomycin-Resistant Enterococcus (VRE): An antibiotic-resistant intestinal bacteria that can cause bloodstream and wound infections.
• CRKP (Carbapenem-Resistant Klebsiella pneumoniae): A highly resistant bacteria that causes serious infections, particularly in immunocompromised patients.

MRSA: Methicillin-Resistant Staphylococcus Aureus

MRSA is a strain of Staphylococcus aureus bacteria that has developed resistance to most common antibiotics, including methicillin, penicillin, and amoxicillin. MRSA infections can range from mild skin infections to life-threatening bloodstream infections, surgical site infections, and pneumonia.

In hospitals, MRSA is typically transmitted through contact with contaminated hands, surfaces, or medical equipment. Healthcare workers who do not perform proper hand hygiene, or who fail to change gloves between patients, can transmit MRSA from one patient to another. Contaminated surfaces (bed rails, doorknobs, medical equipment) can also serve as reservoirs.

The standard of care for preventing MRSA transmission includes:

- Strict hand hygiene (hand washing or alcohol-based sanitizer) before and after every patient contact - Use of personal protective equipment (gloves, gowns) for contact with MRSA-colonized or infected patients - Active surveillance testing — screening high-risk patients for MRSA colonization on admission and periodically - Isolation of MRSA-colonized or infected patients (contact precautions) - Environmental cleaning and disinfection of patient rooms and shared equipment - Antimicrobial stewardship to reduce antibiotic resistance

Failure to follow these protocols can constitute negligence. Some states (including several with mandatory MRSA screening laws) have demonstrated that aggressive screening and isolation programs can dramatically reduce MRSA infection rates.

Clostridioides Difficile (C. Diff)

Clostridioides difficile (C. diff) is a spore-forming bacterium that causes inflammation of the colon (colitis), producing severe, watery diarrhea, abdominal pain, fever, and potentially life-threatening complications including toxic megacolon, bowel perforation, and sepsis. C. diff is responsible for approximately 500,000 infections and 15,000-30,000 deaths annually in the United States.

C. diff infections are most commonly triggered by antibiotic use, which disrupts the normal bacteria in the gut and allows C. diff to proliferate. The bacteria produce spores that are resistant to standard cleaning agents and can survive on surfaces for months. Transmission occurs through the fecal-oral route — typically via contaminated hands of healthcare workers or contaminated surfaces.

The standard of care for preventing C. diff includes:

- Antimicrobial stewardship: Judicious use of antibiotics, avoiding broad-spectrum antibiotics when possible, and limiting duration of therapy. - Hand hygiene: Hand washing with soap and water (alcohol-based sanitizers are less effective against C. diff spores) before and after patient contact. - Contact precautions: Isolating infected patients in private rooms with dedicated equipment. - Environmental cleaning: Using EPA-registered sporicidal disinfectants (bleach-based products) for terminal cleaning of rooms. - Timely testing and treatment: Testing for C. diff when diarrhea develops, and treating promptly with appropriate antibiotics (vancomycin, fidaxomicin).

Failure to follow these protocols — particularly failure to wash hands with soap and water, failure to isolate infected patients, and failure to use sporicidal disinfectants — may constitute negligence.

Surgical Site Infections (SSIs)

Surgical site infections are infections that occur at the site of a surgical incision. They are among the most common healthcare-associated infections, occurring in approximately 2-5% of surgical procedures. SSIs can range from superficial skin infections to deep infections involving muscle, fascia, organs, or implanted material.

The standard of care for preventing surgical site infections includes the Surgical Care Improvement Project (SCIP) measures and CDC guidelines:

- Prophylactic antibiotics: Administering appropriate IV antibiotics within 60 minutes before surgical incision (120 minutes for vancomycin/fluoroquinolones), and discontinuing them within 24 hours after surgery (48 hours for cardiac surgery). - Appropriate hair removal: Using clippers (not razors) if hair removal is necessary, performed immediately before surgery. - Normothermia: Maintaining normal body temperature during surgery (hypothermia increases infection risk). - Glycemic control: Maintaining blood glucose in the target range, particularly for diabetic patients. - Sterile technique: Proper surgical scrubbing, sterile draping, and sterile instrument handling. - Proper wound care: Appropriate post-operative wound management and dressing changes.

Failure to follow these protocols — particularly failure to administer prophylactic antibiotics at the right time, or failure to maintain normothermia — may constitute negligence. [Link to: /surgical-error-lawyer]

Central Line-Associated Bloodstream Infections (CLABSIs)

Central line-associated bloodstream infections (CLABSIs) occur when bacteria enter the bloodstream through a central venous catheter — a large IV placed in a major vein (typically the internal jugular, subclavian, or femoral vein) for administering medications, fluids, nutrition, or for hemodynamic monitoring. CLABSIs are serious, causing sepsis, prolonged hospitalization, and death.

The standard of care for preventing CLABSIs is well-established and includes the central line bundle promoted by the Institute for Healthcare Improvement (IHI):

- Hand hygiene: Washing hands before catheter insertion and before accessing the line. - Maximal barrier precautions: Using sterile gown, gloves, mask, cap, and full-body drape during insertion. - Chlorhexidine skin antisepsis: Preparing the insertion site with chlorhexidine-based antiseptic. - Optimal site selection: Preferring the subclavian site (lowest infection risk) when clinically appropriate; avoiding the femoral site in adults. - Daily review of line necessity: Evaluating each day whether the central line is still needed and removing it promptly when no longer indicated. - Proper maintenance: Using sterile technique for accessing the line, using antiseptic-impregnated dressings, and scrubbing the hub (port) before each access.

Failure to follow the central line bundle is a well-recognized cause of preventable CLABSIs and may constitute negligence.

Catheter-Associated Urinary Tract Infections (CAUTIs)

Catheter-associated urinary tract infections (CAUTIs) are urinary tract infections that develop in patients with urinary catheters. Urinary catheters are common in hospitals, but they carry a significant infection risk — each day a catheter remains in place, the risk of infection increases by 3-7%.

The standard of care for preventing CAUTIs includes:

- Appropriate indication: Inserting catheters only for appropriate clinical reasons (urinary retention, accurate output monitoring in critically ill patients, etc.), not for convenience or incontinence management. - Proper insertion technique: Sterile technique, hand hygiene, and proper perineal cleaning before insertion. - Daily review of necessity: Evaluating each day whether the catheter is still needed and removing it promptly when no longer indicated. - Proper maintenance: Maintaining a closed drainage system, keeping the bag below bladder level, and preventing reflux.

Failure to follow these protocols — particularly leaving catheters in place longer than necessary, or inserting catheters without appropriate indication — may constitute negligence.

Ventilator-Associated Pneumonia (VAP)

Ventilator-associated pneumonia (VAP) is pneumonia that develops in patients on mechanical ventilation (48+ hours after intubation). VAP is a serious complication that increases mortality, prolongs ICU stays, and increases healthcare costs.

The standard of care for preventing VAP includes the ventilator bundle:

- Elevation of the head of the bed: Keeping the head of the bed elevated 30-45 degrees (semi-recumbent position) unless contraindicated. - Daily sedation interruption: Daily assessment for readiness to wean from sedation and the ventilator. - Peptic ulcer disease prophylaxis: Medications to prevent stress ulcers. - Deep vein thrombosis prophylaxis: Measures to prevent blood clots. - Oral care with chlorhexidine: Regular oral hygiene with chlorhexidine rinse to reduce bacterial colonization. - Subglottic secretion drainage: Using endotracheal tubes with subglottic suction ports to remove secretions above the cuff.

Failure to follow the ventilator bundle may constitute negligence. [Link to: /medical-malpractice/icu-negligence]

The Standard of Care for Preventing Hospital Infections

The standard of care for infection prevention in New York hospitals is established by CDC guidelines, The Joint Commission standards, state regulations, and evidence-based practices from professional organizations. Key requirements include:

- Hand hygiene programs: Mandatory hand hygiene before and after every patient contact, using soap and water or alcohol-based sanitizer. - Isolation precautions: Implementing appropriate isolation (contact, droplet, airborne) for patients with known or suspected transmissible infections. - Sterilization and disinfection: Proper cleaning, disinfection, and sterilization of medical equipment and patient environments. - Device-associated infection prevention bundles: Following evidence-based bundles for central lines, urinary catheters, and ventilators. - Antimicrobial stewardship: Programs to optimize antibiotic use and reduce resistance. - Surveillance: Monitoring infection rates, identifying outbreaks, and implementing corrective actions. - Staff training and compliance monitoring: Training staff on infection prevention and monitoring compliance.

Failure to maintain and follow these programs may constitute corporate negligence by the hospital. [Link to: /hospital-negligence/credentialing-negligence]

When a Hospital-Acquired Infection Constitutes Malpractice

A hospital-acquired infection constitutes medical malpractice in New York when the hospital or its staff deviated from the accepted standard of care for infection prevention and that deviation caused the infection. Key considerations include:

- Was the infection preventable? Some infections occur despite proper care. The question is whether specific, identifiable failures in infection prevention protocols caused the infection. - Were evidence-based protocols followed? Did the hospital follow hand hygiene, isolation, device bundle, and sterilization protocols? - Was there a specific breach? For example, failure to administer prophylactic antibiotics before surgery, failure to follow the central line bundle, or failure to isolate a patient with a known transmissible infection. - Did the breach cause the infection? Expert testimony from an infectious disease specialist is required to connect the specific breach to the infection.

Under New York law, expert testimony is required to establish the standard of care and causation. A certificate of merit (CPLR § 3012-a) must be filed with the lawsuit.

Proving Causation in HAI Cases

Proving causation in hospital infection cases can be challenging because infections can occur even with proper care, and the source of the infecting organism is not always clear. The evidence includes:

- Culture and sensitivity results: Identifying the specific organism and its antibiotic resistance pattern, which can help determine whether it is a hospital-acquired strain. - Infection control records: Hospital infection surveillance data showing whether the patient's infection was part of an outbreak or cluster. - Medical records: Documenting whether infection prevention protocols were followed — including hand hygiene audits, isolation orders, antibiotic timing, and device insertion/maintenance documentation. - Expert testimony: From an infectious disease specialist and/or infection control expert, establishing that the standard of care was breached and the breach caused the infection.

The loss of chance doctrine may also apply in HAI cases where the patient had a reduced chance of recovery due to the infection. [Link to: /delayed-diagnosis-lawyer/loss-of-chance]

New York Statute of Limitations

Hospital infection malpractice claims are subject to New York's 2.5-year statute of limitations for medical malpractice (CPLR § 214-a). The clock starts on the date the infection was acquired — typically the date of the negligent act (e.g., the date of a central line insertion without proper technique, or the date prophylactic antibiotics were not given before surgery).

Lavern's Law may extend this to the date you discovered the infection and its cause, with a 7-year outer limit — important because infections may not be diagnosed until days or weeks after the negligent act. The continuous treatment doctrine may also apply if you continued receiving treatment at the same hospital for the infection.

If the infection resulted in death, a wrongful death claim under EPTL § 5-4.1 must be filed within 2 years of the date of death. If the infection occurred at a municipal hospital (NYC Health + Hospitals), shorter deadlines apply — 90 days for the notice of claim and 1 year, 90 days for the lawsuit. [Link to: /hospital-negligence/suing-nyc-h-h] [Link to: /wrongful-death-lawyer]

Common Defense Arguments and How We Counter Them

Defense: "Infections are a known risk of hospitalization."

Defense attorneys use several arguments in HAI cases:

• Our Counter: While some infections may be unavoidable despite proper care, many HAIs are preventable through adherence to evidence-based protocols. We use infection control records, expert testimony, and CDC data to show that the specific infection was preventable and resulted from identifiable protocol failures.

Defense: "We cannot prove the infection was caused by our staff."

Our Counter: We use culture and sensitivity results, infection surveillance data, and molecular typing (when available) to identify the infecting organism and its source. We examine whether the patient was part of a cluster of infections involving the same organism — which suggests a common source in the hospital. Expert testimony from infectious disease specialists establishes the causal connection.

Defense: "The patient had risk factors for infection."

Our Counter: Patients with risk factors (immunocompromise, diabetes, prolonged hospitalization) are exactly the patients for whom infection prevention protocols are most critical. Having risk factors does not excuse the hospital from following the standard of care. We engage experts to show that adherence to protocols would have prevented the infection even in a high-risk patient.

Defense: "The infection was community-acquired, not hospital-acquired."

Our Counter: We use the timing of the infection (48-hour rule for HAIs), culture results, and the patient's admission status to establish that the infection was hospital-acquired. If the organism is a hospital-associated strain (like MRSA or a resistant Klebsiella), the evidence is even stronger.

Compensation Available

A successful hospital infection malpractice claim in New York can provide compensation for:

• Medical expenses (prolonged hospitalization, additional antibiotics, surgical treatment, rehabilitation, ongoing care)
• Lost wages and loss of earning capacity
• Pain and suffering (NY has no cap on non-economic damages)
• Permanent disability from infection complications (amputation, organ damage, cognitive impairment from sepsis)
• Wrongful death damages if the infection caused death

What to Expect Working with MDLaw Firm

When you contact MDLaw Firm about a potential hospital infection case:

• Free Consultation: We listen to your story and review the basic facts.
• Record Retrieval: With authorization, we obtain all medical records, infection surveillance data, and culture results.
• Expert Review: We engage infectious disease specialists and infection control experts to evaluate the standard of care and causation.
• Causation Analysis: We use culture results, surveillance data, and expert testimony to prove the infection was caused by protocol failures.
• Litigation: We file within the statute of limitations and handle all aspects of discovery and trial.
• Resolution: We pursue maximum compensation through settlement or verdict.

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.